purpos
studi
summar
clinic
laboratori
characterist
coronaviru
diseas
patient
admit
intens
care
unit
track
data
march
case
cohort
divid
case
receiv
noninvas
ventil
niv
case
requir
invas
mechan
ventil
imv
characterist
two
group
compar
result
case
includ
studi
complic
rate
includ
acut
liver
injuri
acut
cardiac
injuri
acut
kidney
injuri
higher
imv
case
lymphocytopenia
neutrophilia
occur
case
group
admiss
day
howev
lymphocyt
level
drop
progress
sever
lymphopenia
occur
imv
group
increas
amount
plasma
found
group
admiss
day
progress
decreas
occur
niv
case
rather
imv
case
level
higher
imv
case
hospit
conclus
lymphocytopenia
neutrophilia
increas
occur
infect
patient
icu
howev
dynam
significantli
differ
imv
case
niv
case
hospit
epidem
battl
fatal
rate
hubei
nonhubei
signific
differ
dynam
analysi
characterist
patient
icu
nonhubei
area
may
better
guid
signific
futur
sever
patient
intend
describ
clinic
laboratori
characterist
treatment
outcom
confirm
patient
admit
icu
tertiari
teach
hospit
hangzhou
place
far
away
wuhan
china
depart
critic
care
medicin
hospit
nation
key
clinic
specialti
region
critic
diagnosi
treatment
center
zhejiang
provinc
epidem
sever
patient
transfer
surround
citi
treat
hospit
novel
coronaviru
pneumonia
character
region
represent
retrospect
singlecentr
studi
analys
patient
jan
mar
diagnos
pneumonia
accord
chines
nation
health
acut
kidney
injuri
aki
identifi
accord
kdigo
clinic
practic
guidelin
acut
liver
injuri
defin
increas
alanin
aminotransferas
alt
two
time
upper
limit
normal
rang
uln
conjug
bilirubin
combin
increas
aspart
aminotransferas
ast
alkalin
phosphatas
total
bilirubin
provid
one
two
time
uln
cardiac
injuri
follow
definit
describ
previou
studi
noninvas
ventil
includ
nasal
oxygen
therapi
mask
oxygen
inhal
hfnc
durat
onset
diseas
first
posit
nucleic
acid
test
respiratori
tract
specimen
icu
admiss
ard
hfnc
ippv
ecmo
record
laboratori
test
includ
complet
blood
count
serum
biochemistri
coagul
profil
lactat
dehydrogenas
creactiv
protein
etc
conduct
hospit
laboratori
plasma
cytokin
patient
detect
elisa
method
accord
manufactur
instruct
nk
b
lymphocyt
cell
count
test
flow
cytometri
respiratori
specimen
patient
includ
sputum
pharyng
swab
bronchoalveolar
lavag
fluid
bronchial
aspir
test
use
real
time
revers
transcript
polymeras
chain
reaction
assay
antivir
treatment
use
patient
major
patient
receiv
treatment
corticosteroid
gamma
globulin
specif
dose
determin
chief
physician
accord
patient
condit
antibiot
empir
administ
indic
hfnc
ratio
pf
rest
respiratori
rate
per
minut
patient
consciou
cooper
time
invas
ventil
pf
rest
respiratori
rate
per
minut
uncoop
patient
seriou
complic
shock
indic
ecmo
sever
hypoxemia
eg
pf
despit
applic
high
level
posit
end
expir
pressur
typic
cm
water
least
hr
patient
potenti
revers
respiratori
failur
uncompens
hypercapnia
acidemia
ph
excess
high
endinspiratori
plateau
pressur
cm
water
accord
patient
bodi
size
despit
best
accept
standard
care
manag
ventil
continu
variabl
describ
median
interquartil
rang
compar
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
mannwhitney
u
test
categor
variabl
describ
use
frequenc
rate
percentag
compar
test
fisher
exact
test
twosid
less
consid
statist
signific
analys
perform
use
spss
softwar
version
patient
cohort
divid
case
receiv
niv
case
requir
imv
way
respiratori
support
independ
associ
process
outcom
clinic
laboratori
characterist
two
group
compar
march
case
infect
icu
first
affili
hospit
colleg
univers
hangzhou
investig
case
infect
pregnant
woman
admit
icu
caesarean
section
exclud
except
nt
measur
icu
admiss
standard
final
case
includ
studi
none
resid
wuhan
citi
patient
direct
exposur
huanan
seafood
market
patient
expos
individu
confirm
infect
cluster
onset
case
histori
sojourn
epidem
area
close
contact
peopl
epidem
area
histori
median
durat
onset
symptom
time
first
nucleic
acid
test
posit
iqr
day
median
durat
onset
symptom
icu
admiss
day
hfnc
day
patient
imv
day
case
ecmo
day
patient
fig
median
age
year
iqr
year
men
patient
chronic
diseas
includ
hypertens
diabet
cardiovascular
diseas
chronic
obstruct
pulmonari
diseas
chronic
liver
diseas
chronic
kidney
diseas
common
symptom
onset
ill
fever
dri
cough
expector
tabl
rel
less
common
initi
symptom
myalgia
fatigu
diarrhea
headach
proport
differ
comorbid
distribut
first
symptom
differ
obvious
tabl
blood
cell
count
admiss
show
leukocytosi
white
blood
cell
count
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
case
occur
nearli
half
patient
incid
leucopenia
white
blood
cell
count
less
case
low
lymphopenia
lymphocyt
count
patient
occur
half
patient
admiss
platelet
count
niv
group
higher
imv
group
normal
rang
patient
group
signific
differ
found
niv
imv
group
term
biochem
index
inflamm
immun
indic
coagul
indic
admiss
hospit
tabl
one
patient
receiv
antivir
systemat
corticosteroid
treatment
given
empir
antibiot
treatment
given
gamma
globulin
treatment
complic
rate
includ
acut
liver
injuri
acut
cardiac
injuri
aki
significantli
higher
discharg
rate
notabl
lower
imv
case
compar
niv
patient
tabl
dynam
chang
main
laboratori
indic
progress
includ
blood
cell
count
biochem
paramet
coagul
profil
inflammatori
cytokin
follow
day
day
discharg
day
admiss
interv
white
blood
cell
count
neutrophil
count
high
level
hospit
show
declin
trend
discharg
day
niv
patient
hospit
patient
mark
lymphopenia
imv
patient
develop
sever
lymphopenia
time
lymphocyt
return
normal
level
niv
case
discharg
day
flow
cytometri
show
lymphocyt
count
away
lower
normal
limit
compar
b
lymphocyt
inpati
lymphocyt
count
stay
low
hospit
imv
patient
howev
count
gradual
rose
normal
level
discharg
part
niv
patient
natur
killer
cell
count
inpati
far
lower
normal
limit
count
progress
declin
imv
case
rather
niv
case
hospit
platelet
count
hemoglobin
level
higher
niv
case
imv
case
hemoglobin
level
drop
progress
imv
case
hospit
creactiv
protein
level
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
group
show
gradual
downward
trend
hospit
howev
niv
case
descend
lower
level
faster
rate
alt
ddimer
level
show
upward
trend
group
hospit
total
bilirubin
blood
urea
nitrogen
upward
trend
occur
imv
case
progress
decreas
ldh
level
occur
niv
case
rather
imv
case
hospit
level
higher
imv
case
niv
case
fig
fig
report
cohort
icu
patient
laboratoryconfirm
infect
characteris
sever
critic
coronaviru
pneumonia
patient
men
median
age
year
iqr
oldest
patient
year
old
man
discharg
patient
patient
receiv
noninvas
respiratori
support
includ
nasal
oxygen
therapi
one
case
hfnc
patient
requir
imv
end
mar
complic
rate
includ
acut
liver
injuri
acut
cardiac
injuri
aki
discharg
rate
significantli
differ
two
group
patient
admit
design
hospit
patient
gener
isol
ward
mild
moder
icu
patient
without
imv
requir
got
better
discharg
howev
major
icu
case
imv
requir
still
respiratori
support
includ
ecmo
oper
main
battlefield
epidem
war
icu
key
success
epidem
fight
strive
improv
perfect
manag
treatment
sever
critic
patient
common
complic
ard
patient
research
respiratori
support
essenti
antivir
treatment
proven
effect
coronaviru
infect
infect
patient
receiv
singl
combin
antivir
includ
baloxavir
favipiravir
darunavir
arbidol
interferon
alpha
inhal
corticosteroid
gamma
globulin
administr
part
patient
efficaci
need
confirm
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
lymphocyt
destruct
lymphocytopenia
occur
patient
cohort
first
day
admiss
diseas
progress
patient
develop
lymphocytopenia
imv
group
sever
ill
lymphocyt
level
drop
progress
sever
lymphopenia
occur
compar
noimv
group
suggest
sever
lymphocytopenia
reflect
sever
infect
research
sarscov
infect
case
show
patient
sever
clinic
ill
patient
die
significantli
profound
lymphopenia
lymphocyt
count
gradual
rise
normal
level
discharg
part
patient
without
imv
cohort
lymphopenia
prolong
lymphocyt
return
toward
normal
five
week
ill
patient
sarscov
infect
within
week
diseas
onset
case
sever
pandem
influenza
analysi
cohort
show
lymphocytopenia
pronounc
b
lymphocytopenia
similar
previou
studi
patient
sar
mechan
behind
dynam
clear
need
confirm
cell
anim
experi
note
infect
caus
increas
plasma
level
consist
high
level
imv
case
cohort
earli
studi
also
shown
increas
concentr
proinflammatori
cytokin
eg
sar
patient
merscov
case
increas
amount
antiinflammatori
cytokin
plasma
found
infect
patient
imv
differ
sarscov
infect
support
huang
et
al
patient
diseas
bun
key
element
reflect
intric
interrel
nutrit
statu
protein
metabol
renal
situat
patient
bun
significantli
elev
imv
patient
compar
niv
case
may
caus
high
catabol
characterist
inflamm
metabol
combin
lymphocytopenia
suggest
alert
exist
persist
inflammationimmunosuppress
catabol
syndrom
pic
imv
case
pic
often
lead
secondari
infect
andor
viral
reactiv
critic
ill
associ
increas
morbid
mortal
studi
sever
limit
firstli
limit
sampl
cohort
analyz
previou
report
enrol
critic
ill
patient
infect
wuhan
jin
yintan
hospit
howev
place
outsid
hubei
provinc
total
number
case
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
number
critic
patient
rel
small
secondli
imv
patient
discharg
time
manuscript
submiss
ca
nt
use
surviv
death
clinic
end
point
case
mortal
rate
outcom
indic
need
report
later
singlecent
case
seri
icu
patient
infect
hangzhou
china
patient
complic
ard
receiv
imv
need
noninvas
respiratori
support
compar
case
niv
group
patient
receiv
imv
easier
complic
organ
injuri
develop
sever
lymphopenia
higher
inflammatori
marker
dot
line
show
upper
normal
limit
bun
ldh
p
vs
day
within
group
p
two
group
day
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
